探索了乙型肝炎患者和健康人血清代谢组的差异，寻找与疾病相关的潜在标志物。收集乙肝患者30例、健康对照35例，以气相色谱?质谱联用技术作为研究平台，应用主成分分析、正交偏最小二乘法?判别分析进行模式识别，然后通过变量重要性因子、非参数检验，结合数据库检索筛选鉴定有差异的代谢物。确认10个代谢物存在显著差异，其中柠檬酸、乌头酸、谷氨酰胺、N，N?二甲基甘氨酸、丙二酸与乙型肝炎患者组的相关性较好，受试者工作特征曲线下面积为0?975，具有较好的特异度和敏感度。因此这5个代谢物能够作为潜在的区分乙型肝炎患者和正常人的血清小分子标志物，有助于进一步了解病理机制，确定治疗目标。
The difference of serum metabolome between hepatitis B virus ( HBV ) infected patients and healthy controls was explored for the potential metabolite biomarkers of HBV dis?ease using serum metabolomics approach. Totally 30 HBV infected patients and 35 healthy con?trols were enrolled. Gas chromatography?time?of?flight mass spectrometry ( GC?TOFMS) , pat?tern recognition by principal component analysis ( PCA ) and orthogonal partial least squares?discriminant analysis ( OPLS?DA) were applied in each group. Several metabolites which were different between the two groups based on variable importance in projection ( VIP) value, non?parametric test and screening in databases were identified. Ten variables that were significantly different were considered as the potential biomarkers, among which five variables ( citric acid, aconitic acid, glutamine, N,N?dimethylglycine and malonic acid) showed good correlation with HBV patients. The area under the receiver operating characteristic curve was 0?975, with good specificity and sensitivity. A panel of metabolite markers composed of citric acid, aconitic acid, glutamine, N,N?dimethylglycine and malonic acid from GC?TOFMS were selected to discrimi?nate HBV subjects from their healthy counterparts. These biochemical changes provide a novel molecular diagnostic approach which could be helpful to further understand the pathogenesis and identify the therapeutic target of HBV disease.
参考文献
| [1] | Alter M J.[J].Journal of Hepatology,200644:S6. |
| [2] | 葛均波;徐永健.内科学[M].北京：人民卫生出版社,2014:429. |
| [3] | Ren J J;Liu Y;Ren W.[J].Hepatobiliary & Pancreatec Diseases International,201413(05):495. |
| [4] | 余欣尉;吴谦;吕望;王彦;马小琼;陈喆;阎超.基于液相色谱-质谱联用技术的肺癌细胞代谢组学分析[J].色谱,2013(7):691-696. |
| [5] | Yang J;Zhao XJ;Liu XL;Wang C;Gao P;Wang JS;Li LJ;Gu JR;Yang SL;Xu GW.High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B[J].Journal of proteome research,20063(3):554-561. |
| [6] | Zhang A H;Sun H;Han Y.[J].PLoS One,20138(05):e64381. |
| [7] | Chen S L;Yin P Y;Xu G W.[J].ELECTROPHORESIS,201334:2848. |
| [8] | 盛国平;虞科;徐威.中华医学会全国第九次感染病学学术会议论文汇编[M].成都:中华医学会出版社,2006:1. |
| [9] | Chen T L;Xie G X;Wang X Y.[J].Molecular & Cellular Proteomics,201110(07):M110?004945. |
| [10] | A J;Trygg J;Gullberg J.[J].Analytical Chemistry,200577(24):8086. |
| [11] | Zhou J Y;Yu S J;Wang Y.[J].METABOLOMICS,201410(04):677. |
| [12] | 贾伟.医学代谢组学[M].上海:上海科学与技术出版社,2011:211. |
| [13] | Zong F L;Juan W;Chen H.[J].Rapid Communications in Mass Spectrometry,201024:2765. |
| [14] | 吴谦 .[D].上海:上海交通大学,2014. |
| [15] | Honda A;Yamashita K;Ikegami T.[J].Journal of Lipid Research,200950(10):2124. |
| [16] | Kalonia H;Kumar P;Kumar A.Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats.[J].European Journal of Pharmacology: An International Journal,20101/3(1/3):46-52. |
| [17] | 周君裔 .[D].上海:上海交通大学,2014. |
| [18] | Kim,D.-S.;Jue,S.-S.;Lee,S.-Y.;Kim,Y.-S.;Shin,S.-Y.;Kim,E.-C..Effects of glutamine on proliferation, migration, and differentiation of human dental pulp cells[J].Journal of Endodontics: Official Journal of American Association of Endodontists,20148(8):1087-1094. |
| [19] | Lawson B R;Belkowski S M;Whitesides J F.[J].BMC Complementary and Alternative Medicine,200711(07):20. |
- 下载量()
- 访问量()
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%